PUBLIC HEALTH SELF-SCREENING ASSESSMENT METHOD BASED ON AN INTEGRATED MOBILE APPLICATION

Abstract

This invention relates to a method for self-screening assessment of public health implemented through an interconnected mobile application system, consisting of a health cadre application (E-Cadre), a medical personnel application (E-Doctor), and a central database system (ADMIN System). Health cadres register data and screen subject symptoms through the E-Cadre application, the data of which is automatically forwarded to the E-Doctor application for risk assessment by medical personnel. Based on this assessment, symptomatic subjects are referred to health facilities or directed to undergo self-isolation with regular monitoring by health cadres through the E-Cadre application which is equipped with a reminder feature and a consultation escalation feature to the E-Doctor application if symptoms worsen.All data is automatically consolidated into the ADMIN System which can be accessed by local health offices for coordination and reporting, thus forming a continuous digital workflow (closed-loop) from the community level to the health office level which increases the accuracy and speed of handling infectious disease cases, especially in rural areas with limited professional health workers.

Description

SELF-SCREENING ASSESSMENT SYSTEM Invention Engineering Field The present invention relates to a cellular system which designed for self-screening of public health, especially in the context of monitoring COVID-19 symptoms. This system involving village health cadres who carry out screening, then the results are connected to doctors and health services local. In addition, this invention also aims to improve the health care system by integrating preventive and curative efforts in the monitoring process and COVID-19 patient care. Background of the Invention In the absence of medical treatment and vaccination at the time In this case, analysis of disease prevention and mitigation becomes an aspect important in dealing with the COVID-19 pandemic. Early detection, contact tracing, and case isolation are important parts to control infectious disease outbreaks. Transmission models stochasticity shows that the isolation of confirmed cases and suspected and contact identification can be control the new COVID-19 outbreak within three months (Hellwel et al, 2020). In the early days of the virus, when only There are several cases With the increasing use of mobile phones smart and expanding Internet access in rural Indonesia, innovative mobile technology can be one of the between diverse. With hundreds to thousands of cases, detection early and contact tracing becomes much more difficult. Data shows that as of March 2, 2020, Indonesia has reported 2 confirmed cases of covid-19. Then in period of less than one month (March 29, 2020) increased to 1,285 cases in 30 provinces, the highest provinces in covid-19 cases are Jakarta (6 / 5), West Java (119), Banten (106), East Java (90), and Central Java (63) (Ministry of Health of the Republic of Indonesia, 2020). The increase in the number of cases happened quite quickly and has spread between country. In response to this, WHO declared Covid-19 as a pandemic (Tosepu et al, 2020). With the increasing number of COVID- 19 significant and limited human resources Indonesian health (HRK) causes the long process health data integration which then has an impact on services old and not on target. Since 2016 we have been developing technology innovative multifaceted mobile to control risk cardiovascular disease (CVD) in rural Indonesia, namely SMARTHealth Cardiovascular (Maharani, A., et sal, 2019). SMARTHealth (Systematic Medical Appraisal, Referral and Treatment) is a smartphone-enabled ecosystem that aims to improve health service delivery high quality essential primary health care to community. Built on our collaborative work involving researchers from Brawijaya University, University Manchester and The George Institute Australia, technology SMARThealth is designed to enable screening and effective collection of important health-related information, for SMARThealth to support the provision of preventive care in society by strengthening the existing health system, refers to the subject informing the risk status them, provide lifestyle advice for CVD prevention, and refer high-risk patients for nurse consultation or doctor. the principle of "sharing tasks" This is facilitated by a range of innovative and affordable digital technologies, developed to provide data-based decision support. evidence for providers and consumers. One of the keys The success of SMARThealth innovation is a multifaceted platform mobile technology that can facilitate health cadres village / Posyandu reached 90.68 of the target population (all people adults aged »? 40 years), with 22.9 percent. They identified as high risk for CVD events All These patients are referred to nurses or doctors and managed in sub- primary health centers and facilities (Community Health Centers or Community Health Centers) (helper) Most individuals are at high risk identified by the SMARThealth program Interventions can reach the individuals who are most needed (i.e., people poor, elderly, and women in villages) who have access least to primary health care. Mobile technology SMARThealth enables community health workers to collect important health-related information, inform subjects about their risk status, provide lifestyle advice for CVD prevention, and refer high-risk patients to a community nurse or medical doctor to get medical advice. With the adoption of SMARTHealth technology into increasing COVID-19 screening services in an effort to stop the pandemic will be felt to be effective with a screening pattern that carried out by trained cadres in using the System Self-Screening Assessment. Self-Screening Assessment System Built on our experience and success in implementing the SMARTHealth cardiovascular system in Malang, a project currently designed to develop and build care innovative and multifaceted mobile technology-based primer for the prevention and mitigation of the spread of the COVID-19 pandemic in rural population in Indonesia We call this new system as the SMARTHealth COVID-19 system. Brief Description of the Invention Significant increase in COVID-19 cases causing panic among the public to come in and get checked himself to a health facility. The screening approach through cadres will provide an inclusive effect to patients or suspects COVID-19. In addition, this system is also equipped with a menu self-isolation monitoring that allows cadres to help nurses and doctors supervise the community those who are positive for COVID-19 are advised to isolate themselves independently at home or places suggested by local government. Short Description of Image Figure 1 shows the Bumper View of the Screening Assessment System Independent Figure 2 shows the main menu display of the Assessment System. Self-Screening Figure 3 shows the Assessment System screening menu display. Self-Screening Figure 4 shows the active patient menu view of the Assessment System. Self-Screening Figure 5 shows the System patient search menu display. Self-Screening Assessment Figure 6 shows the Screening Assessment System Flowchart Independent Complete Description of the Invention In making this invention there are three package charts work plan used in completing the invention consists of 1. Analysis of the effectiveness of cellular system technology existing for COVID-19 mitigation in developing countries, 2. Development and implementation of SMARTHealth COVID-19, and 3. Analysis of the effectiveness of SMARThealth COVID-19 in mitigating COVID-19 in rural Indonesia. Analysis of the effectiveness of existing cellular system technologies for COVID-19 mitigation in developing countries. We have conduct a comprehensive study of current cellular systems designed to mitigate the COVID-19 pandemic in the country develop. First, we have examined the relationship between published scientific literature and health assessment systems using commercially available smartphones for contact tracing to identify the percentage of support This second part of the scientific study will focus on the evaluation implementation of mobile assessment technology for COVID-19 screening developed by the Social Security Administration (BPJS) Health, namely the Independent Screening Assessment System COVID-19. This analysis is important to gain an understanding in more depth. some of the main effectiveness factors of existing mobile technologies for screening and mitigation COVID-19. This data will be very useful in the design and our new SMARTHealth implementation of the COVID-19 assessment system 19, Development and implementation of SMARTHealth COVID-19, 1 invention this will use information from the first work package along with our experience in developing systems SMARThealth cardiovascular to design Software Mobile-based Clinical Decision Support System (CDSS) for COVID-19 risk management. SMARTHealth COVID-19 with online referral system (e-Puskesmas) which is currently active in Community Health Center in Malang Regency, East Java. The COVID-19 screening assessment system will record data demographics, symptoms, travel history, history of contact with confirmed COVID-19 patients, information on the condition that has been pre-existing conditions such as hypertension, heart disease, and diabetes, as well as body temperature. will train cadres to collect and enter data using the assessment system COVID-19 screening. Information on how to provide advice to possible COVID-19 patients. The role of cadres will be very important important as frontline workers in early detection of COVID- 19 patients and the information provided in the assessment system COVID-19 screening will be very useful for health workers (nurses and doctors at the Community Health Center) who will take action further in diagnosis, treatment, isolation and contact tracing of suspected cases. As this invention is implemented we plan to implementing the COVID-19 screening assessment system in 390 village in Malang Regency in East Java, Indonesia Our target is to train at least 40 primary care physicians and 80 nurses in primary health services (Puskesmas). serving population of 2.4 million in the region using COVID-19 screening assessment system. Cooperation and coordination with the Malang Regency Health Service to implement This program has started. Before walking in Malang Regency, we did trial or sampling test in Kediri Regency. Kediri was chosen as the control district because it has similar characteristics (rural and population density) with Malang Regency. Six months after our implementation collect data on people at risk, COVID-19 patients and results treatment in comparison will be done on the number of individuals screened, the number of high-risk individuals monitored regularly by nurses and doctors, the number of patients recovered followed up by nurses, the number of infected individuals, the number of high-risk patients referred to hospital and the number death. COVvID Screening Assessment System Effectiveness Analysis Package- 19 in rural Indonesia, producing main outputs such as comprehensive report for policy makers in Indonesia, which explains program implementation, accuracy and evaluation. This report will use RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance). REACH (estimated absolute number, proportion, and representation of individuals participating in the program): This will be projected by comparing the number and individual characteristics captured in the Tracker database Symptoms of COVID-19 Indonesia (as a result of services any health ) provider interaction) with the data that taken in the basic household survey. EFFECTIVENESS (the impact of the program on important outcomes, including potential adverse effects, acceptability, and outcomes economy): the number of people diagnosed with COVID-19, use of health services related to COVID-19, and mortality will be the desired main outcome. and acceptability will be examined using qualitative methods. ADOPTION ("health system readiness") institutional for adopt the program with an understanding of the facilitator and main obstacles): This will be determined by a system assessment early rapid health, as well as detailed process evaluations that will happen after implementation. IMPLEMENTATION (fidelity of program implementation, including delivery consistency, time and cost): As explained above, the unique monitoring nature of Indonesia COVID-19 Symptom The tracker will provide accurate information about the accuracy at all critical points in the care process. This also will be explored qualitatively through process evaluation. MAINTAINANCE (the extent to which the program can be institutionalized or become part of routine organizational practices and policies) This will also be determined by an assessment of the health system. quick start, as well as detailed process evaluation that will occur post-implementation to identify possible facilitators and barriers to implementation and maintenance.

Claims

1. The Self-Screening Assessment System is effective in maintaining and mitigation and handling of the COVID-19 pandemic. Where This cellular system can encourage people to be able to play an active role. The following are the monitoring steps patient Independent: COVID-19 using the Screening Assessment System - Patient Registration a. Health cadres start by collecting basic patient information, such as name, age, address, and health history through the system E-Kader mobile. This data will be used as basis for further monitoring. .patient information is stored in the system and can be accessed by authorized medical personnel. - Symptom Screening a. Health cadres fill out the symptom screening form COVID-19 in the E-Kader mobile system, which includes questions about symptoms such as fever, cough, shortness of breath, and history of contact with patients confirmed COVID-19. b. This symptom data is automatically sent to the system E-Doctor mobile used by medical personnel. — Risk Assessment a. Based on data inputted by cadres health, the E-Doctor mobile system will perform initial risk assessment and provide recommendations does the patient need a referral to a health facility? or can self-isolate. - Patient Referral a. If the risk assessment shows a level of high severity, the system will recommend that patients be referred to a facility nearest health. b. Patient data and screening results will be forwarded to ADMIN system in the Health Service for coordination Furthermore. - Self-Isolation Monitoring a. For patients who are advised to isolate themselves independent, health cadres make routine visits (both physical and virtual) and record development of symptoms in the cellular system. b. The FE-Kader mobile system is also equipped with reminder feature for cadres to do regular monitoring. - Consultation with a Doctor a. If symptoms develop worrying during self-isolation, cadres can connect patients with medical personnel through the E-Doctor mobile system for consultation Furthermore. - Reporting and Evaluation a. All collected data will be consolidated in ADMIN system owned by the Health Service for further analysis and action. b. An overall evaluation is carried out to ensure effectiveness of monitoring and to adjust next steps if necessary.

2. The Self-Screening Assessment System enables data integration fast and accurate, ensuring that COVID-19 patients get timely and quality monitoring according to their needs.

Images